Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Coatings TrendsCoatings Trends
Not Confirmed
Not Confirmed
03-05 September, 2025
Not Confirmed
Not Confirmed
04-06 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Coatings TrendsCoatings Trends
Industry Trade Show
Not Confirmed
03-05 September, 2025
Industry Trade Show
Not Confirmed
04-06 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
02 Sep 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-09-02/us-food-and-drug-administration-fda-approves-henlius-and-organon-s-bildyos-denosumab-nxxp-and-b
29 Aug 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761444
29 Aug 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761444
02 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/hanchorbio-and-henlius-sign-major-licensing-deal-for-hcb101-to-expand-global-immuno-oncology-reach-302495363.html
01 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/hanchorbio-and-henlius-sign-major-licensing-deal-for-hcb101-to-expand-global-immuno-oncology-reach-302495363.html
29 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/29/3070486/0/en/Sandoz-enters-global-collaboration-license-agreement-with-Henlius-to-commercialize-leading-oncology-therapy-ipilimumab-in-multiple-indications.html
ABOUT THIS PAGE